Shield Therapeutics (GB:STX) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Shield Therapeutics has launched a RetailBook Offer, allowing existing UK shareholders to purchase new ordinary shares at a premium price of 3.0p per share, raising up to £1 million. This offer is available through partners like AJ Bell and Hargreaves Lansdown and can be accessed using ISAs or SIPPs. The offer closes on December 20, 2024, with no commission charged by RetailBook.
For further insights into GB:STX stock, check out TipRanks’ Stock Analysis page.